Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 26 2023 - 8:30AM
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,
oncology-focused biopharmaceutical company developing proprietary
antibody-based therapeutics to treat multiple human diseases, today
announced that the Company will participate in the H.C. Wainwright
BioConnect Investor Conference in New York City on Tuesday, May 2,
2023.
Fireside Chat
details:Date: Tuesday, May
2Time: 10 AM ETWebcast:
https://journey.ct.events/view/059d01ae-0fdd-4419-8329-ac44f76cc2fc
Virtual/Replay availability: The corporate
presentation will be archived for 90 days on Compass’ Events
page.
About Compass TherapeuticsCompass Therapeutics,
Inc. is a clinical-stage, oncology-focused biopharmaceutical
company developing proprietary antibody-based therapeutics to treat
multiple human diseases. Compass’s scientific focus is on the
relationship between angiogenesis, the immune system, and tumor
growth. Compass’s pipeline of novel product candidates is designed
to target multiple critical biological pathways required for an
effective anti-tumor response. These include modulation of the
microvasculature via angiogenesis-targeted agents, induction of a
potent immune response via activators on effector cells in the
tumor microenvironment, and alleviation of immunosuppressive
mechanisms used by tumors to evade immune surveillance. Compass
plans to advance its product candidates through clinical
development as both standalone therapies and in combination with
proprietary pipeline antibodies based on supportive clinical and
nonclinical data. Compass was founded in 2014 and is headquartered
in Boston, Massachusetts. For more information, visit the Compass
Therapeutics, Inc. website at www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Communications
Managermedia@compasstherapeutics.com 617-500-8099
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From Apr 2024 to May 2024
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From May 2023 to May 2024